Even after the expiration of Humira’s patent protection, AbbVie, the pharmaceutical company, almost completely fended off biosimilar competition for this blockbuster medicine in the Netherlands. ‘Their behaviour defies any description.’ By Lucien Hordijk On Monday, 29 October 2018, two sales representatives of the US pharmaceutical giant AbbVie were received in the boardroom of Maasstad Hospital …

Evergreening the world’s most profitable medicine Read More »